Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04239014
Title A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment. (DUETTE)
Acronym DUETTE
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN

Facility Status City State Zip Country Details
Research Site Anchorage Alaska 99508 United States Details
Research Site La Jolla California 92093-0021 United States Details
Research Site Long Beach California 90806 United States Details
Research Site Los Angeles California 90048 United States Details
Research Site West Hollywood California 97210 United States Details
Research Site Hartford Connecticut 06106 United States Details
Research Site Tampa Florida 33612 United States Details
Research Site Atlanta Georgia 30342 United States Details
Research Site Louisville Kentucky 40202 United States Details
Research Site Covington Louisiana 70433 United States Details
Research Site Florham Park New Jersey 07932 United States Details
Research Site Teaneck New Jersey 07666 United States Details
Research Site Cleveland Ohio 44106 United States Details
Research Site Oklahoma City Oklahoma 73104 United States Details
Research Site Tulsa Oklahoma 74146 United States Details
Research Site Portland Oregon 97210 United States Details
Research Site Abington Pennsylvania 19001 United States Details
Research Site Philadelphia Pennsylvania 19104 United States Details
Research Site Sioux Falls South Dakota 57105-1599 United States Details
Research Site Sioux Falls South Dakota 57105 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Seattle Washington 98104 United States Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Montreal Quebec H3A 1A1 Canada Details
Research Site Napoli 80131 Italy Details
Research Site Barcelona 8035 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field